Why sports medicine practices consider SoftWave
Overuse and tendinopathy injuries — Achilles tendinopathy, patellar tendinopathy, calcific shoulder tendinopathy — are among the conditions with the strongest published evidence for shockwave therapy, according to independent systematic review data summarized on our Clinical Evidence page.
For active patients weighing conservative care against injections or surgery, a non-invasive option with a defined visit cadence is often an easy conversation to have — especially for in-season athletes trying to avoid downtime.
Patient population
- Achilles and patellar tendinopathy
- Calcific tendinopathy of the shoulder
- Overuse injuries in recreational and competitive athletes
- Patients trying to avoid or delay injection-based intervention
Appropriateness for any individual patient is always a clinical decision made by the treating provider.
How it fits your workflow
SoftWave can be positioned as part of a broader return-to-play plan alongside existing rehab and load-management protocols — it's an addition to your treatment toolkit, not a rebuild of how you manage an athlete's recovery timeline.
Sports Medicine-specific FAQ
Yes — it's commonly used as a complementary modality alongside an existing rehab plan rather than a standalone protocol.
Independent systematic review data has found good supporting evidence for shockwave therapy in Achilles tendinopathy and calcific shoulder tendinopathy specifically. See the Clinical Evidence page for sourcing.